Suppr超能文献

用于更复杂剂量探索研究的扩展基于模型的设计。

Extended model-based designs for more complex dose-finding studies.

机构信息

Inserm, Université Paris VI, Place Jussieu, 75005 Paris, France.

出版信息

Stat Med. 2011 Jul 30;30(17):2062-9. doi: 10.1002/sim.4024. Epub 2011 Feb 24.

Abstract

We discuss extensions of model-based designs, such as the continual reassessment method, for use in dose-finding studies. Rather than work with a single model to carry out the design and analysis of a dose-finding study we indicate how the use of several models can greatly increase flexibility. We can appeal to established results on Bayesian model choice and this device makes the inferential problem essentially straightforward. The greater flexibility enables us to take on board many different kinds of added complexity. Examples include extended models to deal with subject heterogeneity, extended models to take account of different treatment schedules and extended models to tackle the problem of partial ordering.

摘要

我们讨论了基于模型的设计的扩展,如连续再评估方法,用于剂量发现研究。我们不是使用单一模型来进行剂量发现研究的设计和分析,而是指出使用多个模型可以大大增加灵活性。我们可以诉诸于贝叶斯模型选择的既定结果,这种方法使推理问题变得非常简单。更大的灵活性使我们能够处理许多不同类型的附加复杂性。例如,扩展模型以处理个体间的异质性,扩展模型以考虑不同的治疗方案,以及扩展模型以解决部分排序问题。

相似文献

1
Extended model-based designs for more complex dose-finding studies.
Stat Med. 2011 Jul 30;30(17):2062-9. doi: 10.1002/sim.4024. Epub 2011 Feb 24.
2
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation.
Clin Trials. 2020 Oct;17(5):522-534. doi: 10.1177/1740774520932130. Epub 2020 Jul 7.
3
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data.
Clin Trials. 2017 Dec;14(6):611-620. doi: 10.1177/1740774517723829. Epub 2017 Aug 2.
4
Phase I design for completely or partially ordered treatment schedules.
Stat Med. 2014 Feb 20;33(4):569-79. doi: 10.1002/sim.5998. Epub 2013 Sep 30.
5
Comparative review of novel model-assisted designs for phase I clinical trials.
Stat Med. 2018 Jun 30;37(14):2208-2222. doi: 10.1002/sim.7674. Epub 2018 Apr 22.
6
Continual reassessment and related designs in dose-finding studies.
Stat Med. 2011 Jul 30;30(17):2057-61. doi: 10.1002/sim.4215. Epub 2011 Feb 24.
8
The continual reassessment method for dose-finding studies: a tutorial.
Clin Trials. 2006;3(1):57-71. doi: 10.1191/1740774506cn134oa.
9
Choice of designs and doses for early phase trials.
Fundam Clin Pharmacol. 2004 Jun;18(3):373-8. doi: 10.1111/j.1472-8206.2004.00226.x.
10
A comparison of two phase I trial designs.
Stat Med. 1994 Sep 30;13(18):1799-806. doi: 10.1002/sim.4780131802.

引用本文的文献

1
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
Clin Trials. 2024 Jun;21(3):308-321. doi: 10.1177/17407745231212193. Epub 2024 Jan 19.
2
Flexible Phase I-II design for partially ordered regimens with application to therapeutic cancer vaccines.
Stat Biosci. 2020 Jul;12(2):104-123. doi: 10.1007/s12561-019-09245-3. Epub 2019 Jun 4.
3
The Impact of Early-Phase Trial Design in the Drug Development Process.
Clin Cancer Res. 2019 Jan 15;25(2):819-827. doi: 10.1158/1078-0432.CCR-18-0203. Epub 2018 Oct 16.
4
Shift models for dose-finding in partially ordered groups.
Clin Trials. 2019 Feb;16(1):32-40. doi: 10.1177/1740774518801599. Epub 2018 Oct 11.
5
Embracing model-based designs for dose-finding trials.
Br J Cancer. 2017 Jul 25;117(3):332-339. doi: 10.1038/bjc.2017.186. Epub 2017 Jun 29.
6
Implementation of adaptive methods in early-phase clinical trials.
Stat Med. 2017 Jan 30;36(2):215-224. doi: 10.1002/sim.6910. Epub 2016 Feb 29.
7
The changing landscape of phase I trials in oncology.
Nat Rev Clin Oncol. 2016 Feb;13(2):106-17. doi: 10.1038/nrclinonc.2015.194. Epub 2015 Nov 10.
8
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial.
Pharm Stat. 2015 Jul-Aug;14(4):302-10. doi: 10.1002/pst.1686. Epub 2015 May 11.
10
Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents.
J Biopharm Stat. 2015;25(5):903-20. doi: 10.1080/10543406.2014.920873. Epub 2014 Jun 6.

本文引用的文献

1
Retrospective robustness of the continual reassessment method.
J Biopharm Stat. 2010 Sep;20(5):1013-25. doi: 10.1080/10543400903315732.
2
Model calibration in the continual reassessment method.
Clin Trials. 2009 Jun;6(3):227-38. doi: 10.1177/1740774509105076.
3
Designs for single- or multiple-agent phase I trials.
Biometrics. 2004 Sep;60(3):661-9. doi: 10.1111/j.0006-341X.2004.00215.x.
4
Continual reassessment method for ordered groups.
Biometrics. 2003 Jun;59(2):430-40. doi: 10.1111/1541-0420.00050.
5
A simple technique to evaluate model sensitivity in the continual reassessment method.
Biometrics. 2002 Sep;58(3):671-4. doi: 10.1111/j.0006-341x.2002.00671.x.
7
Two-sample continual reassessment method.
J Biopharm Stat. 1999 Mar;9(1):17-44. doi: 10.1081/BIP-100100998.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验